The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s 3D cell culture technologies market report forecasts the 3D cell culture technologies market size to grow to $5.65 Billion by 2027, with a CAGR (compound annual growth rate) of almost 19%.

Learn More On The 3D Cell Culture Technologies Market Report 2023 – https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

3D Cell Culture Technologies Market Size Forecast
The global 3D cell culture technologies market is expected to grow from $2.39 billion in 2022 to $2.83 billion in 2023 at a compound annual growth rate (CAGR) of 18.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The 3d cell culture technologies market is expected to grow from $5.65 billion in 2027 at a CAGR of 18.9%.

North America held the largest 3D cell culture technologies market share.

Key 3D Cell Culture Technologies Market Driver ­– Increase In Requirement For Organ Transplantation
For instance, according to the Organ Procurement and Transplantation network, an American non-profit organization administering the organ transplantation in the US, 41,354 organ transplantations were performed in the United States in 2021 which was an increase of 5.9% as compared to 2020 and the number exceeded 40,000 mark for the first time ever..

Request for A Sample Of The Global 3D Cell Culture Technologies Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2462&type=smp

Key 3D Cell Culture Technologies Market Trend – Implementing The Latest Technology
For example, various companies have adopted one such advancement in the market for 3D cell culture, this is the use of the vivo/vitro environment. Cell expansion and interactions under 2D are not appropriate in vitro models but when compared with 3D cell culture technique, it offers a better cell culture environment. The Vitro environment enables researchers or doctors to conduct the procedure in a controlled environment outside the organism. This procedure is gaining importance as it plays a vital role in monitoring the health of patients. FDA approved Biotek’s 3D cell expansion system to be used as a medical device. It also approved Biotek’s Polycaprolactone (PCL) which is a biodegradable polyester material that is used in many FDA-approved implants and drug delivery devices.

3D Cell Culture Technologies Market Segment
1) By Type: Scaffold-based, Scaffold-free, 3D Bioreactors
2) By End Users: Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users
3) By Scaffold-based: Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates
4) By Scaffold-free: Hanging Drop Microplates, Spheroid Microplates, Microfluidic 3D Cell Culture, Magnetic Levitations & 3D Bioprinting
5) By Application: Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine

3D Cell Culture Technologies Market Major Players and Strategies
Major players in the 3D cell culture technologies market are Becton Dickinson, Corning Incorporation, Eppendorf, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Lonza, HiMedia Laboratories, Agilent Technologies, PromoCell GmbH, CellGenix GmbH, InvivoGen, Greiner Bio-One, Irvine Scientific, Cell Culture Company (CCC) LLC., Sera Care Life Sciences Incorporation, American Type Culture Collection, Miltenyi Biotec, AITbiotech, ESSEN, Sigma-Aldrich, Bel-Art, MilliporeSigma, Cellgenix, Sumitomo Bakelite, EMD Millipore, AffymetrixInc., VWR International, LLC., WHEATON IndustriesInc., and Sartorius AG.

In May 2021, CELLINK Group, a USA-based start-up that designs and supplies technologies and services to enhance biology research, has acquired Visikol Corporation for $7.5 million. With this acquisition, CELLINK made an entrance into the contract research market. Visikol Corp., an American contract research services company that provides pharma and biotech industries with leading services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology.

The 3D Cell Culture Technologies Global Market Report 2023 covers regional data on 3D cell culture technologies market size, 3D cell culture technologies market trends and drivers, opportunities, strategies, and 3D cell culture technologies market competitor analysis. The countries covered in the 3D cell culture technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Cell culture is a process for developing substrates for the safe production of viral vaccines. 3D cell culture is an in vitro technique wherein the cells can grow in an artificially created environment.

View More Reports Related To The 3D Cell Culture Technologies Market –
3D Diagnostic Imaging Services Global Market Report 2023
Cell Culture Consumables And Equipment Global Market Report 2023
Cell Culture Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: